Hosted on MSN
Cassava Sciences stock on track for worst day in about 9 months — what’s driving today’s selloff?
・Cassava said that it intends to work “expeditiously” with the FDA and address the items flagged by the agency. ・The company added that it no longer expects to initiate the trial in question in the ...
AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (SAVA) (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments ...
NEW YORK, Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Cassava Sciences, Inc. (NASDAQ: SAVA) breached their ...
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Austin-based Cassava Sciences ...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results